par Bosly, André;Grigg, Andrew;Holte, Harald;Gisselbrecht, Christian;Radford, John;Rossi, Andrea;Lopez-Guillermo, Armando;Trneny, Marek;Sebban, Catherine;Hagberg, Hans;da Costa, Fernando Leal;Colombat, Philippe;Bron, Dominique ;Coiffier, Bertrand
Référence The oncologist, 18, 11, page (1189)
Publication Publié, 2013
Référence The oncologist, 18, 11, page (1189)
Publication Publié, 2013
Article révisé par les pairs
Titre: |
|
Auteur: | Bosly, André; Grigg, Andrew; Holte, Harald; Gisselbrecht, Christian; Radford, John; Rossi, Andrea; Lopez-Guillermo, Armando; Trneny, Marek; Sebban, Catherine; Hagberg, Hans; da Costa, Fernando Leal; Colombat, Philippe; Bron, Dominique; Coiffier, Bertrand |
Informations sur la publication: | The oncologist, 18, 11, page (1189) |
Statut de publication: | Publié, 2013 |
Sujet CREF: | Cancérologie |
MeSH keywords: | Antineoplastic Combined Chemotherapy Protocols -- therapeutic use |
Combined Modality Therapy | |
Consolidation Chemotherapy | |
Disease Progression | |
Disease-Free Survival | |
Female | |
Humans | |
Interferon-alpha -- therapeutic use | |
Lymphoma -- drug therapy -- surgery | |
Male | |
Middle Aged | |
Prospective Studies | |
Recombinant Proteins -- therapeutic use | |
Recurrence | |
Stem Cell Transplantation -- methods | |
Transplantation Conditioning -- methods | |
Transplantation, Autologous | |
Note générale: | SCOPUS: ar.j |
Langue: | Anglais |
Identificateurs: | urn:issn:1083-7159 |
info:doi/10.1634/theoncologist.2013-0223 | |
info:pii/theoncologist.2013-0223 | |
info:scp/84887420090 | |
info:pmid/24105750 | |
PMC3825302 |